Form 10-Q INSULET CORP For: Sep 30

Go back to Form 10-Q INSULET CORP For: Sep 30

Insulet Corporation (PODD) PT Raised to $234 at Barclays

November 11, 2024 5:53 AM EST

Barclays analyst Matt Miksic raised the price target on Insulet Corporation (NASDAQ: PODD) to $234.00 (from $220.00) while maintaining a Equalweight rating.

The analyst comments "PODD Rallies on Q3 Beat, Fueled by International (+$19MM), Drug Delivery (+$7MM) and Rising Expectations for the T2 Pump Launch: Mgmt delivered a strong beat to vs. our estimates and Bloomberg... More